This list is an analysis based on recent market events. It's not an investment recommendation.
About
Gencurix Inc. provides diagnostic solutions in South Korea. Its products include GenesWell BCT, a multigene diagnostic test for breast cancer; Droplex, a genetic test based on digital PCR platform; eDX, an early diagnosis for cancer with liquid biopsy; GenePro SARS-CoV-2 Test kit; GenoCTC, a circulating tumor cell isolator; and GenePro LAMP Cycler, a portable device for infectious disease detection. The company has a strategic alliance with Qiagen N.V. for the development of oncology assays for use on the QIAcuityDx platform. The company was founded in 2011 and is headquartered in Seoul, South Korea.
The current price of 229000.KQ is ₩3,895 KRW — it has increased by +5.13% in the past 24 hours. Watch Gencurix stock price performance more closely on the chart.
What is Gencurix stock ticker?▼
Depending on the exchange, the stock ticker may vary. For instance, on exchange Gencurix stocks are traded under the ticker 229000.KQ.
What is Gencurix market cap?▼
Today Gencurix has the market capitalization of 62.78B
What is Gencurix revenue for the last year?▼
Gencurix revenue for the last year amounts to 10.27B KRW.
What is Gencurix net income for the last year?▼
229000.KQ net income for the last year is -7.25B KRW.